First Trust Small Cap Growth AlphaDEX Fund (FYC)
| Assets | $700.65M |
| Expense Ratio | 0.70% |
| PE Ratio | 23.65 |
| Shares Out | 7.35M |
| Dividend (ttm) | $0.08 |
| Dividend Yield | 0.08% |
| Ex-Dividend Date | Sep 25, 2025 |
| Payout Ratio | 1.90% |
| 1-Year Return | +13.95% |
| Volume | 64,045 |
| Open | 96.96 |
| Previous Close | 96.80 |
| Day's Range | 96.23 - 97.24 |
| 52-Week Low | 59.29 |
| 52-Week High | 97.30 |
| Beta | 1.15 |
| Holdings | 265 |
| Inception Date | Apr 18, 2011 |
About FYC
Fund Home PageThe First Trust Small Cap Growth AlphaDEX Fund (FYC) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Small Cap Growth index. The fund tracks a quant-driven index that select stocks from a small-cap growth universe in an attempt to outperform the market. FYC was launched on Apr 18, 2011 and is issued by First Trust.
Top 10 Holdings
9.74% of assets| Name | Symbol | Weight |
|---|---|---|
| Praxis Precision Medicines, Inc. | PRAX | 1.27% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 1.16% |
| Cidara Therapeutics, Inc. | CDTX | 1.13% |
| Arcutis Biotherapeutics, Inc. | ARQT | 0.97% |
| Alphatec Holdings, Inc. | ATEC | 0.90% |
| Travere Therapeutics, Inc. | TVTX | 0.89% |
| Globalstar, Inc. | GSAT | 0.88% |
| Avadel Pharmaceuticals plc | AVDL | 0.86% |
| Lemonade, Inc. | LMND | 0.84% |
| GRAIL, Inc. | GRAL | 0.84% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 25, 2025 | $0.0776 | Sep 30, 2025 |
| Dec 13, 2024 | $0.1473 | Dec 31, 2024 |
| Sep 26, 2024 | $0.344 | Sep 30, 2024 |
| Jun 27, 2024 | $0.0699 | Jun 28, 2024 |
| Dec 22, 2023 | $0.1555 | Dec 29, 2023 |
| Sep 22, 2023 | $0.0772 | Sep 29, 2023 |
News
FYC: Small-Cap Exposure With Mixed Growth Metrics
The Invesco First Trust Small Cap Growth AlphaDEX ETF offers diversified, rules-based exposure to U.S. small-cap growth stocks with a unique sector mix. FYC outperforms both the Russell 2000 and small...
FYC: High Fee, High Risk, Little Reward From Growthier SMID Stocks
FYC is a passively managed ETF targeting high-growth names in the small-cap arena. FYC has beaten a few SMID peers since the index change but underperformed the market proxied with IVV. Risk metrics, ...
Why Is The IPO Market Struggling? Here's What Active Managers Have To Say
Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of companies going public via the IPO process — as well as the potential impl...
FYC: A Smart Or Speculative Small-Cap Growth ETF?
FYC holds 262 small-cap growth stocks selected based on three short-term screens: price momentum, sales to price ratio, and one-year sales growth. Its expense ratio is high at 0.70%. While these scree...
